Skip to main content

chlorpheniramine

Generic: CHLORPHENIRAMINE MALEATE·Brand: ANTAGONATE, Aller-Chlor, CHLOR-TRIMETON, CHLORPHENIRAMINE MALEATE, Chlor-Trimeton, EFIDAC 24 CHLORPHENIRAMINE MALEATE, KLOROMIN, PHENETRON, PYRIDAMAL 100, Poly Hist PD, TELDRIN, Tannic-12 S, Tussionex, Tuxarin, Tuzistra, Ventuss, Wal-finate, Z Tuss AC, Zodryl AC, Zodryl DAC

chlorpheniramine: 1 clinical trial tracked.

chlorpheniramine evidence translation

What we can confirm

1 tracked trial

No verified listed company relationship

What it means

AI will separate confirmed drug evidence from unknown company context.

What to watch

Watch trial status, endpoints, and the next source-backed update.
BioSniper AIPage evidence connected

Prepared research question

What is verified about chlorpheniramine, and what remains unknown?

Run cited research

Traceable citations · Unknowns marked

See linked entities and source evidence0 indications · 1 study sponsors

Related indications

No linked indication is available.

Clinical Trial Registry Records (1)

A Multicenter, Randomized, Double-blind, Placebo-controlled, Dose-escalation Study to Determine the Depth and Duration of Hepatitis B Surface Antigen (HBsAg) Reduction After a Single Intravenous Dose of ARC-520 in Combination With Entecavir in Patients With Chronic Hepatitis B Virus (HBV) Infection, Followed by a Two-dose Open-label Cohort and Three Open-label Single-dose Cohorts in Treatment Naïve Patients, Including a Multi-dose Open-label Extension at a Single Center

NCT02065336Registry updated 2026-01-13·Phase 2·ARWR
Terminated

Primary endpoint: Change From Baseline Over Time in Quantitative Hepatitis B Surface Antigen (HBsAG)

InterventionalRandomizedtriple58 targetStarted 2014-03Completion 2017-012 sites · Hong KongArrowhead Pharmaceuticals